We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Capvaxive
Australian Public Assessment Report
Device/Product Name
Capvaxive
Active ingredients
Pneumococcal 21-valent Conjugate Vaccine
AusPAR Date
Published
Submission Number
PM-2023-05219-1-2
Submission Type
New biological entity
Decision
Approved